Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic …
PR Newswire (press release) SAN ANTONIO, Feb. 23, 2013 /PRNewswire/ — Boehringer Ingelheim presented today a new subset of data from the Phase III UniTinA-asthma™ program at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in San … |
View full post on asthma – Google News